Joanna Bakala

USPTO Granted Patents = 10 (Patent Applications = 2)

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 11(Granted Patents)

Company Filing History:

10 out of 5,081

Centre National De La Recherche Scientifique

patents

1 out of 1

Institut European De Biologic Cellulaire

patent

1 out of 2

Centre De Recherches Biologiques Et D'experimentations Cutanees

patents

where one patent can have more than one assignee

Years Active: 2007-2021

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10947273 - Peptides of use in the preventive and curative treatment of alopecia (2021-03-16),

2. 10233151 - Use of a novel 3-aryl-4-catechol-pyrrole-N-propanol compound and the derivatives thereof to treat cancer and diseases related to excessive angiogenesis (2019-03-19),

3. 9546159 - N-substituted 3,4-bis (catechol) pyrrole compounds, and the preparation and use thereof in the treatment of cancer (2017-01-17),

4. 9512176 - Age inhibitors (2016-12-06),

5. 8697652 - Cosmetic use of at least the natural tetrapeptide Ac-Ser-Asp-Lys-Pro or one of its analogs as a skin restructuring agent (2014-04-15),

6. 8273768 - Iso CA-4 and analogues thereof as potent cytotoxic agents inhibiting tubuline polymerization (2012-09-25),

7. 8080524 - Agent for slowing hair loss and/or stimulating hair growth (2011-12-20),

8. 7405309 - Pyranone derivatives useful for treating cancer (2008-07-29),

9. 7235532 - Angiogenic agents and their uses (2007-06-26),

10. 7199159 - Use of biguanide derivatives for making a medicine having a wound healing effect (2007-04-03),

Title: Innovator Joanna Bakala: Pioneering Solutions in Biomedicine

Introduction

Joanna Bakala, an accomplished inventor based in Paris, France, has made significant contributions to the field of biomedicine. With a remarkable portfolio of ten patents, she has focused on developing innovative solutions for pressing health issues, particularly in the areas of alopecia and cancer treatment.

Latest Patents

Among her latest inventions are groundbreaking peptide conjugates designed for both preventive and curative treatments of alopecia. This patent introduces a novel family of peptide conjugates with a specific formula aimed at addressing hair loss effectively. Additionally, she has developed a new compound, a 3-aryl-4-catechol-pyrrole-N-propanol, and its derivatives, specifically targeting the treatment of cancer and conditions related to excessive angiogenesis. These patents not only underscore her innovative approach but also reflect her commitment to advancing medical science for better patient outcomes.

Career Highlights

Throughout her career, Joanna Bakala has worked with prestigious research institutions such as the Centre National de la Recherche Scientifique and the Institut Européen de Biologie Cellulaire. Her time at these organizations has allowed her to deepen her expertise and collaborate on significant research projects that embody her inventive spirit and dedication to scientific advancement.

Collaborations

Joanna has collaborated closely with notable professionals in her field, including Jérôme Bignon and Maria Concepcion Achab. These partnerships have facilitated the exchange of ideas and fostered an environment of innovation, driving the development of her patented solutions.

Conclusion

Joanna Bakala stands out as a prominent inventor in the realm of biomedical innovations. Her substantial contributions through her patents and collaborations demonstrate her unwavering commitment to advancing medical treatments and highlight the importance of continued research and development in the health sector. As she moves forward, the impact of her work is likely to resonate in the medical community and beyond, inspiring future innovations.

This text is generated by artificial intelligence and may not be accurate.